Two simple, sensitive and economical spectrophotometric methods have been developed for the determination of amiodarone hydrochloride in pure form and commercial dosage form. These methods (A and B) are based on the reaction of amiodarone base as n-electron donor with p-chloranilic acid and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) as π-acceptors to give highly colored complex species which absorb maximally at 535 and 570 nm, respectively. Beer's law is obeyed in the concentration ranges 10.0 -360.0 and 2.0 -65.0 µg ml -1 for methods A and B, respectively. Application of the proposed methods to commercial pharmaceutical tablets are presented.
Amiodarone hydrochloride, 2-butyl-3-benzofuranyl-4-[2-diethylamino]ethoxy]-3,5-diiodophenyl methanone hydrochloride, is an important antiarrhythmic drug; [1] [2] [3] it is used only in the treatment of documented life-threatening recurrent ventricular dysrhythmias.
British Pharmacopoeia 4 describes potentiometric titration and spectrophotometric methods for the assay of amiodarone hydrochloride in pure from and pharmaceutical formulations, respectively. The different analytical techniques that have been reported for the determination of this drug in biological fluids and pharmaceutical formulations include high performance liquid chromatography, [5] [6] [7] [8] [9] [10] high performance thin layer chromatography, 11 liquid chromatography, 12,13 infrared spectroscopy, 14 fluorometry, 15 and electrochemical methods. 16, 17 In the literature only few spectrophotometric methods have been reported. Sastry et al. 18 have described two spectrophotometic methods for the determination of amiodarone hydrochloride based on its reaction with a known excess of iodine or ammonium molybdate; one can estimate the unreacted iodine or reduced ammonium molybdate with metol-sulfanilic acid or potassium thiocyanate. The reaction 19 between amiodarone and citric acid-acetic anhydride reagent yielded an intensely bluecolored product, whose absorbance was measured at 580 nm. The drug content in pharmaceutical formulations was also determined spectrophotometrically 20 using the charge transfer complexation reaction of the drug with chloranil and iodine at 500 and 290 nm, respectively.
The extractive spectrophotometric methods 21 have also been utilized for the estimation of the drug in pharmaceutical formulations.
This work describes two rapid and simple visible spectrophotometric methods for the determination of amiodarone hydrochloride by exploiting its basic nature and its electron donating property. The methods (A and B) are based on charge transfer complexation reactions of amiodarone base with p-chloranilic acid and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) in dioxan-dichloromethane and acetonitrile media, respectively. The proposed methods are validated statistically.
Experimental

Apparatus
Spectral runs and absorbances were recorded on a Spectronic 20 D + spectrophotometer (Milton Roy Company, USA) with 1 cm matched glass cells.
Reagents and standards
Amiodarone hydrochloride was kindly provided by Troikaa Pharmaceuticals Ltd. India and was used as received. Commercial dosage forms of amiodarone hydrochloride such as Aldarone (Zydus Alidac), Amiodar (Cardicare), Duron (Samarth Pharma) and Eurythmic (Troikaa) were purchased from a local market.
All other reagents used were of analytical grade. Solutions of p-chloranilic acid (0.08%; Fluka, Switzerland) and DDQ (0.08%; Fluka, Switzerland) were prepared in dioxan and acetonitrile, respectively. An aqueous solution of sodium carbonate (0.5 M, Merck, India) was prepared in doubly distilled water.
The standard solutions of amiodarone base (2.0 mg ml -1 and 0.5 mg ml -1 ) were prepared in dichloromethane.
Recommended procedures
Preparation of amiodarone base. To prepare amiodarone base solution, we transferred 25.0 ml of 0.2% (2 mg ml -1 ) amiodarone hydrochloride and 50.0 ml of 0.5 M Na2CO3 solutions into a 250 ml separating funnel. The contents of the separating funnel were mixed well and shaken for 1 min. The two layers were then allowed to separate. The dichloromethane layer dried over anhydrous sodium sulfate and diluted to 25 ml with dichloromethane.
A working standard solution of amiodarone base (0.05%; 0.5 mg ml dilution. Method A. Aliquots of 0.2% amiodarone base solution (0.025 -0.90 ml) were pipetted into a series of 5.0 ml standard volumetric flasks. A 1.5-ml volume of 0.08% p-chloranilic acid was added to each flask and the content was diluted to volume with dichloromethane.
The colored product formed immediately and remained stable for 1.5 h. The absorbance was measured within the stability period (2 -90 min) after dilution at 535 nm against the reagent blank prepared simultaneously. Method B. Aliquots of 0.05% amiodarone base corresponding to 10.0 -325.0 µg were pipetted into a series of 5.0 ml standard volumetric flasks. To each flask, 1.5 ml of 0.08% DDQ was added and the content was completed to volume with acetonitrile. The absorbance was measured at 570 nm within the stability period of 3.0 -40 min against the reagent blank prepared similarly, omitting the drug.
Procedure for determination of commercial dosage forms
Ten tablets were powdered, mixed thoroughly and weighed accurately to an amount equivalent to 200 mg of amiodarone hydrochloride.
The mixture was stirred well with dichloromethane and filtered through a piece of Whatmann No. 42 filter paper. The residue was washed with dichloromethane for complete recovery of the drug. The filtrate and washings were diluted to volume in a 100 ml standard flask. The amiodarone hydrochloride solution was converted into amiodarone base following the recommended procedure given under the head "Preparation of amiodarone base". It was further diluted according to the need and then analyzed, following the recommended procedures.
Results and Discussion
The spectrum of p-chloranilic acid in the dioxandichloromethane mixture exhibits an absorption band at 440 nm. The addition of amiodarone base to this solution causes an immediate shift with a new characteristic band at 535 nm. The band may be attributed to the formation of a p-chloranilic acid radical anion. The p-chloranilic acid in dioxan-dicholoromethane medium exists in un-ionized form and acts as π-acceptor in a similar manner to quinones. 22 Some hydrochloride salts of amines do not possess a lone pair of electrons and hence are unable to react with σ or π-acceptors. Similarly, amiodarone hydrochloride does not react with pchloranilic acid owing to non-availability of n-electrons. In order to establish the assay procedure for amiodarone hydrochloride, it is necessary to convert amiodarone hydrochloride solution into amiodarone base solution. Due to the same reason, amiodarone hydrochloride was dissolved in dichloromethane and shaken with a 0.5 M aqueous sodium carbonate solution, resulting in the formation of amiodarone base in the dichloromethane layer. The addition of p-chloranilic acid to amiodarone base (n-donor) results in the formation of a charge transfer complex of the n-π type. This compound is believed to be an intermediate molecular association complex, which dissociates in dioxan-dichloromethane solvent, producing p-chloranilic acid radical anion. The mole ratio method 23 has been applied to establish the stoichiometric ratio of amiodarone base to p-chloranilic acid and was found to be 1:1. This indicated the presence of one n-donating center in the amiodarone base for charge transfer complexation reaction. On the basis of a literature background search and our experimental findings, a reaction mechanism is proposed (Scheme 1).
DDQ is π-acceptor, which reacts instantaneously with basic nitrogenous compounds to form charge transfer complexes of the n-π type. The absorption spectrum of DDQ in acetonitrile shows a characteristic band peaking at 350 nm. The addition of amiodarone base to this solution causes an immediate change in the absorption spectrum, with new characteristic bands peaking at 435, 540 and 570 nm. These bands may be attributed to the formation of DDQ radical anions, which probably resulted from the dissociation of the donor-acceptor complex in a highly polar solvent like acetonitrile. In order to avoid the maximum interference from the reagent blank, we made the absorbance measurements at 570 nm. The mole ratio method suggested a donor to acceptor ratio of 1:1, confirming the presence of one ndonating center in the amiodarone base molecule. The reaction sequence for the formation of DDQ radical anion is shown in Scheme 2.
The molar absorptivities and association constants for amiodarone-p-chloranilic acid and amiodarone-DDQ reaction products were calculated using the Ross and Labes equation: (Fig. 1) .
The molar absorptivities and association constant for methods A and B were found to be 1.42 × 10 3 and 7.50 × 10 3 lmol -1 cm -1 ; and 1.11 × 10 3 and 3.86 × 10 2 lmol -1 , respectively.
Optimization of variables
The spectrophotometric properties of the colored species formed with p-chloranilic acid and DDQ, as well as the different parameters affecting the color development, were extensively studied. The optimum conditions for the assay procedures (method A and B) have been established by studying the reactions as a function of the concentration of reagent, the nature of the solvent and the stability of the colored species.
For method A, the effect of the volume of 0.08% p-chloranilic acid was studied over the range of 0.2 -1.5 ml; in a solution containing 360 µg ml -1 amiodarone. The results revealed the fact that 1.0 ml of p-chloranilic acid was required to achieve the maximum intensity of the color. Therefore, 1.5 ml was used as an optimum value and maintained throughout the experiment. The reaction gets stabilized within 2.0 min of mixing at room temperature and the absorbance remained constant for a further 90 min.
For method B, the only effective variable is the concentration of DDQ. To study the influence of the volume of 0.08% DDQ, we pipetted an aliquot of drug containing 300 µg into a series of 5.0 ml standard volumetric flasks, followed by varying volumes of 0.08% DDQ (0.1 -1.5 ml). The contents were diluted to volume with acetonitrile. The highest absorbance was obtained with 1.0 ml of 0.08% DDQ. Further addition of DDQ caused no change in the absorbance, so 1.5 ml was selected as an optimum volume for all determinations. The intensity of the color formed on mixing the reagent reached maximum within 3 min and was stable up to 35 min at room temperature. Therefore, it is recommended that the absorbance be measured within this time period.
Analytical data
The linear calibration curves were obtained over the concentration ranges 10 -360 and 2 -65 µg ml -1 of amiodarone hydrochloride for methods A and B, respectively. The least square treatment of calibration data (n = 9) yielded the regression equations: A = 3.515 × 10 -5 + 2.706 × 10 -3 C and A = 2.734 × 10 -4 + 1.100 × 10 -2 C for methods A and B, respectively. In each method, the correlation coefficient was found to be 0.9999, indicating the excellent linearity of the calibration curves. The values of confidence limit 25 at 95% confidence level for slopes (2.706 × 10 -3 ± 6.769 × 10 -6 and 1.100 × 10 -2 ± 2.816 × 10 -5 for methods A and B, respectively) and intercepts (3.515 × 10 -5 ± 1.480 × 10 -3 and 2.734 × 10 -4 ± 1.085 × 10 -3 for methods A and B, respectively) of the regression lines pointed towards high reproducibility of the proposed methods. Test of significance of the intercept of the regression lines showed that the experimental intercepts, a, for methods A and B do not differ significantly from the theoretical value of zero. For this justification, a simplified method was used to calculate the quantity from the relation t = a/Sa, 26 and its comparison with the tabulated data from the t-distribution. The t-value for methods A and B were found to be 0.056 and 0.596, respectively, which did not exceed the tabulated t-value (t = 2.365, when ν = 7) at 95% confidence level. It confirmed that intercepts for the proposed methods are not significantly different from zero. Thus the present methods are free from constant errors independent of the concentration of the amiodarone hydrochloride.
The detection limit 27 for methods A and B were calculated and found to be 1.091 and 0.161 µg ml -1 , respectively. The small value of the variance (1.048 × 10 -6 and 6.408 × 10 -7 µg ml -1 for methods A and B, respectively) confirmed the small degree of scatter of experimental data points around the line of regression. Both the detection limit and the slope of the calibration graphs indicated the good sensitivity.
The error (Sc) in the determination of a given concentration of amiodarone was calculated by using the following expression: 28 1233 ANALYTICAL SCIENCES AUGUST 2004, VOL. 20 The value of Sc may be used to establish the confidence limit at the selected level of significance for the determination of unknown concentrations by using the relation Ci ± tSc. The results are shown in Fig. 2 by plotting percentage uncertainty versus the concentration of amiodarone hydrochloride 29 at 95% confidence level. Hence the confidence limits established for both methods (A and B) can be used to evaluate the relative uncertainty directly on the concentration over the full range of the concentration tested.
The reproducibility of the proposed methods was checked by estimating three different concentration levels within the Beer's law limit in six replicates. The analytical results obtained from this investigation are summarized in Table 1 . The standard deviation, relative standard deviation and standard analytical error 30 can be considered to be very satisfactory. The validity of the proposed methods for the determination of drug in commercial dosage forms was tested by applying standard addition technique. In this study, a known amount of pure amiodarone was added to pre-analyzed commercial dosage forms. The recoveries were obtained in the range of 99.98 -100.12%. The results are summarized in Table 2 . The common excipients present in formulations did not interfere.
The applicability of the proposed methods for the determination of amiodarone in commercial dosage form was
examined by analyzing marketed products such as Aldarone (Zydus Alidac), Amiodar (Cardicare), Duron (Samarth), Eurythmic (Troikaa). The results of the proposed methods were statistically compared with those obtained by the reference method 19 and are summarized in Table 3 . It is evident from the table that the calculated t and F values 31 are less than the theoretical ones at 95% confidence level, indicating no significant difference between the methods compared.
The proposed methods are quite selective as the drug contains one basic center, which preferentially interacts with pchloranilic acid and DDQ. A substance having no nitrogen (no basic center) in the organic moiety will not give any color reaction with polyhalo/poly cyanoquinones. Both the methods show no interference from the common excipients and additives. The statistical parameters and the recovery data reveal good accuracy and precision of the proposed methods. Therefore, it is concluded that the proposed methods are simple, sensitive and rapid for the determination of amiodarone in pure form and commercial dosage forms. Hence, the present approach encourages their successful use in routine analysis of the drug in quality control laboratories. Table 2 Standard addition method for the determination of amiodarone in dosage form a. Mean ± SD for six independent analyses. b. SAE, standard analytical error. c. C.L., confidence limit at 95% confidence level and five degrees of freedom (t = 2.571). 
